THEPRED 125 by Chemisis Pharmaceuticals contains Methylprednisolone Sodium Succinate, a corticosteroid used for its potent anti-inflammatory and immunosuppressive properties. This medication is commonly administered to treat a wide range of conditions, including severe allergies, asthma, rheumatoid arthritis, lupus, multiple sclerosis, and various inflammatory or autoimmune disorders. It is also used to manage severe acute conditions such as shock, cerebral edema, and certain types of cancer. Methylprednisolone works by suppressing the immune response and reducing inflammation, thereby alleviating symptoms such as swelling, redness, and pain. It achieves this by inhibiting the release of substances in the body that cause inflammation. The typical dosage and administration of THEPRED 125 depend on the specific condition being treated and the patient’s response to therapy. It is administered via intravenous or intramuscular injection, usually in a clinical or hospital setting under the supervision of a healthcare professional. Common side effects may include increased appetite, weight gain, nausea, vomiting, headache, dizziness, and trouble sleeping. Long-term use can lead to more serious side effects such as osteoporosis, high blood pressure, diabetes, increased risk of infections, and Cushing’s syndrome. Patients should be closely monitored by their healthcare provider to manage and mitigate these risks.